NinePoint Medical completed a $34 million Series B financing led by Corning Inc., along with founding investors Third Rock Ventures and Prospect Venture Partners.
Proceeds from the financing will support the ongoing commercial launch of the NvisionVLE Imaging System in the United States as well as development of the company's expanded product offering. The NvisionVLE Imaging System enables physicians and pathologists to endoscopically view real-time, high-resolution, cross sectional images of organs and tissues up to 3mm deep at better than 10 micron resolution.
The company also added Corning's Curt Weinstein and independent directors Tom Miller and Mark Stautberg to its board of directors.
More Articles on Healthcare:
8 Recent ASC Industry Leadership Moves & Honors
8 Key Thoughts for ASCs on Out-of-Network Services
20 Surgery Centers Expected to Open in 2014
Proceeds from the financing will support the ongoing commercial launch of the NvisionVLE Imaging System in the United States as well as development of the company's expanded product offering. The NvisionVLE Imaging System enables physicians and pathologists to endoscopically view real-time, high-resolution, cross sectional images of organs and tissues up to 3mm deep at better than 10 micron resolution.
The company also added Corning's Curt Weinstein and independent directors Tom Miller and Mark Stautberg to its board of directors.
More Articles on Healthcare:
8 Recent ASC Industry Leadership Moves & Honors
8 Key Thoughts for ASCs on Out-of-Network Services
20 Surgery Centers Expected to Open in 2014